Krystal Biotech, Inc. - 10-Q Filing
Krystal Biotech reports Q3 2026 financial results including segment performance for KB111, KB113, and BVEC.
Tickers: $KRYS
Read the full article at SEC EDGAR
Part of the story Krystal Biotech, Inc. - 10-Q Filing (14 articles)